FOXP3 and neoplasm: To confirm that RANKL/RANK signaling recruits Tregs via the CCL20–CCR6 pathway, we discovered that CCR6 and FOXP3 were colocalized in the blood (Fig. 5c) and tumor tissue (Fig. 5d) of CRC.